HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takuji Yamauchi Selected Research

Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)

1/2016Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takuji Yamauchi Research Topics

Disease

5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 10/2009
5Leukemia
01/2022 - 01/2016
3Primary Myelofibrosis (Myelosclerosis)
11/2023 - 01/2016
3Neoplasms (Cancer)
06/2023 - 01/2017
2Infections
08/2022 - 01/2022
2Cytomegalovirus Infections (Inclusion Disease)
08/2022 - 01/2022
2Anemia
02/2022 - 12/2021
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016 - 01/2010
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2023
1Diarrhea
06/2023
1Edema (Dropsy)
06/2023
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2023
1Hyperplasia
02/2022
1Carcinoma (Carcinomatosis)
01/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Connective Tissue Diseases (Connective Tissue Disease)
01/2020
1Sarcoidosis (Schaumann Disease)
01/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
12/2018
1Multiple Myeloma
04/2017
1Chromosome Aberrations (Chromosome Abnormalities)
01/2017
1Essential Thrombocythemia
01/2016
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2016
1Lymphoma (Lymphomas)
01/2016
1Disease Progression
01/2016
1Aspergillosis
07/2011
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2010
1Sepsis (Septicemia)
12/2009

Drug/Important Bio-Agent (IBA)

1Liposomes (Liposome)IBA
03/2024
1Cytarabine (Cytosar-U)FDA LinkGeneric
03/2024
1Daunorubicin (Cerubidine)FDA LinkGeneric
03/2024
1ruxolitinibIBA
11/2023
1tisagenlecleucelIBA
06/2023
1Chimeric Antigen ReceptorsIBA
06/2023
1CreatinineIBA
06/2023
1letermovirIBA
08/2022
1Immunoglobulin G (IgG)IBA
08/2022
1purineIBA
01/2022
1Tyrosine (L-Tyrosine)FDA Link
01/2022
1gilteritinibIBA
01/2022
1Cadherins (E-Cadherin)IBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1Immune Checkpoint ProteinsIBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
15- ((1- (2,6- dichlorobenzyl)piperidin- 4- yl)methoxy)quinazoline- 2,4- diamineIBA
01/2019
1EnzymesIBA
12/2018
1RNA Precursors (Precursor, mRNA)IBA
12/2018
1Proteasome InhibitorsIBA
04/2017
1Bortezomib (Velcade)FDA Link
04/2017
1Lenalidomide (CC 5013)FDA Link
04/2017
1Immunomodulating AgentsIBA
04/2017
1Thalidomide (Thalomid)FDA Link
04/2017
1StilbenesIBA
01/2017
1gnetin CIBA
01/2017
1Monoclonal AntibodiesIBA
01/2016
1CalreticulinIBA
01/2016
1Janus Kinase 2IBA
01/2016
1CCR4 ReceptorsIBA
01/2016
1mogamulizumabIBA
01/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2010
1Gemtuzumab (Mylotarg)FDA Link
10/2009

Therapy/Procedure

5Transplantation
08/2022 - 10/2009
3Therapeutics
03/2024 - 07/2011
2Hematopoietic Stem Cell Transplantation
01/2022 - 01/2016
1Immunotherapy
06/2023
1Cell Transplantation
08/2022
1Blood Component Removal (Apheresis)
12/2021
1Stem Cell Transplantation
07/2011
1Cord Blood Stem Cell Transplantation
01/2010
1Drug Therapy (Chemotherapy)
10/2009